Target intelligence / Profile preview

Neutrophil cytosol factor 1 (NCF1) (NCF1)

Target
NCF1
Molecular classification
Adaptor protein, PX domain-containing protein, NADPH oxidase subunit
01

Overview

Neutrophil cytosol factor 1 (NCF1), commonly known as p47phox, is a critical cytosolic subunit of the multi-protein NADPH oxidase (NOX2) complex responsible for generating reactive oxygen species (ROS) (UniProt P14598). The Phox homology (PX) domain of p47phox plays a pivotal role in this process by mediating the protein's recruitment to the plasma or phagosomal membrane through specific interactions with phosphoinositides, particularly PI(3)P and PI(3,4)P2 (PubMed: 11739770). Upon cell activation, p47phox undergoes phosphorylation, triggering a conformational change that exposes the PX and SH3 domains, allowing the cytosolic complex to assemble with the membrane-bound cytochrome b558 (PubMed: 15590945). This assembly is essential for the production of superoxide anions, which are vital for microbial killing but can also drive tissue damage if dysregulated (PubMed: 17449725). Consequently, p47phox is a significant therapeutic target for inflammatory and autoimmune conditions where oxidative stress is a primary driver, such as rheumatoid arthritis and cardiovascular diseases (PubMed: 24659618). Conversely, genetic deficiencies in NCF1 lead to chronic granulomatous disease, highlighting its essential role in the innate immune response (NIH: Genetic Home Reference).

Other names
p47phoxp47-phoxNADPH oxidase organizer 2NOXO247 kDa neutrophil oxidase factorNeutrophil NADPH oxidase factor 1
02

Mechanism of action

Inhibition of NADPH oxidase complex assembly by disrupting the translocation of p47phox to the membrane or its interaction with p22phox (PubMed: 24659618).

03

Biological functions

Superoxide anion generationPhagocytosisSignal transductionPhosphoinositide bindingProtein-protein interaction
04

Disease associations

Chronic granulomatous diseaseInflammationRheumatoid arthritisSystemic lupus erythematosusCardiovascular diseaseAtherosclerosisHypertensionNeurodegenerative disease
05

Safety considerations

Increased susceptibility to bacterial and fungal infections (e.g., Staphylococcus aureus, Aspergillus)Impaired innate immune responsePotential for Chronic Granulomatous Disease-like phenotypeImpaired wound healing
06

Interacting drugs

Apocynin (Acetovanillone)

4 more in the full profile.

07

Biomarkers

Reactive oxygen species (ROS) levelsNCF1 phosphorylation statusNCF1 genetic polymorphisms (e.g., rs201802880)Nitroblue tetrazolium (NBT) reduction test

Beyond the preview

Go deeper on Neutrophil cytosol factor 1 (NCF1) (NCF1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neutrophil cytosol factor 1 (NCF1) (NCF1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call